Ftse Mib
33.676,84
-0,26%
DAX
19.826,70
-0,45%
S&P 500
5.930,85
0,00%
NASDAQ
19.572,60
0,00%
Bitcoin
95.170,93
0,06%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Molecular Templates Inc (MTEM) Molecular Templates Inc (MTEM) Notizie

Molecular Templates Inc

MTEM
0,1549
-0,0051 (-3,19%)
Pre Mercato
Ultimo aggiornamento: 14:57:21
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/12/202422:11EDGAR2Form 8-K - Current report
19/12/202422:10GLOBEMolecular Templates Announces Notice of Delisting and..
04/12/202422:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
04/12/202422:05EDGAR2Form 8-K - Current report
04/12/202412:04EDGAR2Form 8-K - Current report
02/12/202423:06GLOBEMolecular Templates Announces Receipt of Expected..
26/11/202422:35EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/11/202422:31EDGAR2Form 8-K - Current report
15/11/202412:05EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
12/11/202415:31EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
28/10/202422:20EDGAR2Form DEF 14A - Other definitive proxy statements
17/10/202423:05EDGAR2Form PRE 14A - Other preliminary proxy statements
11/10/202422:39EDGAR2Form 8-K - Current report
04/10/202422:02EDGAR2Form 8-K - Current report
30/9/202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/9/202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/9/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/9/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/9/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202422:01EDGAR2Form 8-K - Current report
14/8/202422:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202422:26EDGAR2Form 8-K - Current report
14/8/202422:21GLOBEMolecular Templates, Inc. Reports Second Quarter 2024..
13/8/202422:47EDGAR2Form ARS - Annual Report to Security Holders
13/8/202422:44EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
13/8/202422:43EDGAR2Form DEF 14A - Other definitive proxy statements
03/6/202414:13EDGAR2Form 8-K - Current report
03/6/202414:11GLOBEMolecular Templates, Inc. Provides Interim Update
15/5/202423:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202423:18EDGAR2Form 8-K - Current report
15/5/202423:11GLOBEMolecular Templates, Inc. Reports First Quarter 2024..
09/4/202414:11GLOBEMolecular Templates Presents Interim Data from MT-6402 Phase..
29/3/202413:21GLOBEMolecular Templates, Inc. Reports Fourth Quarter 2023..
28/3/202413:11GLOBEMolecular Templates Announces $9.5 Million Private Placement..
04/3/202414:11GLOBEMolecular Templates, Inc. Provides Interim Update
15/2/202402:39EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202422:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202423:55GLOBEMolecular Templates to Present at Oppenheimer 34th Annual..
25/1/202423:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:04EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 0,16

La tua Cronologia

NASDAQ
MTEM
Molecular Templates
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network